MediView Announces First Clinical Use of FDA-Cleared XR90 Augmented Reality-Based Visualization and Navigation Platform
CLEVELAND, Nov. 9, 2023 /PRNewswire/ -- MediView XR, Inc., a leading clinical augmented reality (AR) med-tech company, announced today the first inpatient utilization of its XR90 AR-based surgical visualization and navigation system since its 510(k) clearance from the U.S. Food and Drug Administration.
- CLEVELAND, Nov. 9, 2023 /PRNewswire/ -- MediView XR, Inc., a leading clinical augmented reality (AR) med-tech company, announced today the first inpatient utilization of its XR90 AR-based surgical visualization and navigation system since its 510(k) clearance from the U.S. Food and Drug Administration.
- The system is intended to be used adjunctively for minimally invasive ultrasound and CT guided needle-based procedures for soft tissue and bone.
- "We are pleased at the successful utilization of our holographic visualization and navigation system," said Mina Fahim, President and CEO of MediView.
- Dr. Pua then used the holographic needle tracking feature of the XR90 system to plan his approach before confirming on standard of care.